INTEL CORPORATION v. QUALCOMM INCORPORATED
- CAFC Updates
- December 28, 2021
Qualcomm owns U.S. Patent No. 8,838,949, which claims systems for efficiently retrieving an executable software image...
Posts From 2021
ASTRAZENECA AB v. MYLAN PHARMACEUTICALS INC.
- CAFC Updates
- December 08, 2021
AstraZeneca sued for infringement of all claims of U.S. Patent Nos. 7,759,328; 8,143,239<span style="font-weight:...
MODERNATX, INC. v. ARBUTUS BIOPHARMA CORPORATION
- CAFC Updates
- December 01, 2021
Moderna appeals from the Board’s IPR decision holding that certain claims of U.S. Patent 9,364,435 are not...
Seminar: The Legality of Cannabis and its Impact on IP Rights
- News
- November 30, 2021
Carter, DeLuca & Farrell LLP is proud to announce that our partner, Pina Campagna, will be a panelist discussing The Legality of Cannabis...
INDIVIOR UK LIMITED v. DR. REDDY’S LABORATORIES S.A.
- CAFC Updates
- November 24, 2021
Dr. Reddy’s petitioned for inter partes review of Indivior’s U.S. Patent 9,687,454 relating to orally dissolvable films containing therapeutic agents. The Board held certain claims unpatentable, but...
Long Island Capital Alliance (LICA) Food, Beverage, and AgTech Capital Forum
- News
- November 16, 2021
Carter, DeLuca and Farrell LLP is pleased to be a platinum sponsor of the Long Island Capital Alliance (LICA), which is an...
ROHM SEMICONDUCTOR USA, LLC v. MAXPOWER SEMICONDUCTOR, INC.
- CAFC Updates
- November 12, 2021
ROHM and MaxPower entered into a technology license agreement permitting ROHM to use certain power metal oxide semiconductor field effect transistors (‘MOSFET’)-related technologies...
CARTER, DELUCA & FARRELL LLP OPENS NEW OFFICE IN DALLAS, TEXAS
- News
- October 15, 2021
Carter, DeLuca & Farrell LLP is pleased to announce the expansion of the law firm by the addition of a new satellite...